Skip to content

Meet us at COP31Read more

Quantum BioPharma Ltd Sustainability Reports

Quantum BioPharma Ltd. is a biopharmaceutical company specializing in the research and development of treatments for neurodegenerative disorders, metabolic disorders, and alcohol misuse disorders. Its lead pipeline candidate is Lucid-MS, a patented clinical-stage compound being developed for the treatment of multiple sclerosis.

Sector: Manufacturing

Country: Canada

Exchange: Canadian Securities Exchange

LEI: 529900Z3CEEEN7U9B668

7 reports from 2019 to 2025